Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a systematic review and meta-analysis
Article in Expert Review of Hematology (April 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience
Article in Platelets (January 2023)
Illustrated treatment of refractory immune thrombotic thrombocytopenic purpura with caplacizumab
Article in BMJ Case Reports (August 2021)